Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Liver Transplantation
100%
Optimal Timing
100%
Cost-effectiveness Analysis
100%
Hepatitis C Treatment
100%
Post-liver Transplantation
71%
Hepatitis C Virus
57%
MELD Score
57%
Hepatitis C Virus Recurrence
57%
Cost-effective Strategy
42%
Hepatitis C Virus Genotypes
28%
Treatment Strategy
14%
Liver Transplant Recipients
14%
Graft Failure
14%
Decompensated Cirrhosis
14%
Hepatocellular Carcinoma
14%
Living Donor Liver Transplantation
14%
Ribavirin
14%
Cost-effectiveness
14%
Cirrhotic Patients
14%
Comparative Cost-effectiveness
14%
Viremia
14%
Median Models
14%
Transplant Listing
14%
Separate Treatment
14%
Markov State Transition Model
14%
Medicine and Dentistry
Liver Transplantation
100%
Hepatitis C
100%
Cost-Effectiveness Analysis
100%
Hepatitis C Virus
69%
Recurrent Disease
38%
Health Care Cost
30%
Model For End Stage Liver Disease Score
15%
Model for End-Stage Liver Disease
15%
Diseases
7%
Allograft
7%
Base
7%
Decompensated Liver Cirrhosis
7%
Hepatocellular Carcinoma
7%
Living Donor
7%
Ribavirin
7%
Quality Adjusted Life Year
7%
Viremia
7%
Hepatitis C Virus Genotype 4
7%
Hepatitis C Virus Genotype 1
7%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C
100%
Hepatitis C Virus
100%
Recurrent Disease
55%
End Stage Liver Disease
44%
Diseases
11%
Liver Cell Carcinoma
11%
Base
11%
Ribavirin
11%
Decompensated Liver Cirrhosis
11%
Viremia
11%
Hepatitis C Virus Genotype 1
11%
Hepatitis C Virus Genotype 4
11%
Immunology and Microbiology
Hepatitis C
100%
Liver Transplantation
100%
Hepatitis C Virus
69%
Allograft
7%
Ribavirin
7%
Viremia
7%
Hepatitis C Virus Genotype 1
7%
Quality Adjusted Life Year
7%
Hepatitis C Virus Genotype 4
7%
Biochemistry, Genetics and Molecular Biology
Hepatitis C Virus
100%
Ribavirin
11%
Quality Adjusted Life Year
11%
Viremia
11%
Hepatitis C Virus Genotype 1
11%
Hepatitis C Virus Genotype 4
11%